Dyslipidemia Treatment in Diabetes Mellitus Patients / 대한내과학회지
Korean Journal of Medicine
; : 686-689, 2014.
Article
en Ko
| WPRIM
| ID: wpr-219261
Biblioteca responsable:
WPRO
ABSTRACT
Cardiovascular disease (CVD) is the major cause of mortality and morbidity in patients with type 2 diabetes mellitus. The increased risk of CVD in subjects with type 2 diabetes mellitus involves multiple factors, including hypertension, smoking, albuminuria, and hypercholesterolemia. Of these, hypercholesterolemia is amenable to intervention. A large body of research ranging from molecular to population studies indicates that elevated low-density-lipoprotein cholesterol (LDL-C) is a major predictor of CVD, including in the population with diabetes. Despite available therapies and increased attention to hypercholesterolemia, many patients fail to achieve the LDL-C goals. A patient-tailored approach to dyslipidemia therapy, as determined by baseline LDL-C levels, is an effective strategy for achieving target LDL-C levels.
Palabras clave
Texto completo:
1
Base de datos:
WPRIM
Asunto principal:
Humo
/
Enfermedades Cardiovasculares
/
Fumar
/
Colesterol
/
Mortalidad
/
Diabetes Mellitus
/
Diabetes Mellitus Tipo 2
/
Albuminuria
/
Dislipidemias
/
Hipercolesterolemia
Tipo de estudio:
Prognostic_studies
Límite:
Humans
Idioma:
Ko
Revista:
Korean Journal of Medicine
Año:
2014
Tipo del documento:
Article